FacultyFaculty/Author Profile
Paul Fehlner

Paul Fehlner

Novartis Pharma AG (Former)
Pharmaceutical Lawyer, Former Global Head of Pharma Intellectual Property
Nanuet, NY, USA


Paul Fehlner is a lawyer and Principal of Life Sciences Innovation LLC, a consulting company he founded in 2017 to advise on complex IP business strategy for products and technologies in life sciences, develop capabilities of legal and IP professionals, and provide BD&L support for research institutes, companies, and investors.

Previously, Dr. Fehlner was Head of Intellectual Property for Novartis Pharma in Basel, Switzerland. In this role, he led a team responsible for obtaining, maintaining, and enforcing IP rights. The team created a holistic IP portfolio around Pharma’s products, including patents, trademarks, regulatory exclusivities, and reputation. They worked closely with global R&D and commercial organizaitons, local country organizations, and third-party stakeholders to ensure Novartis had a foundation to bring lifesaving and life-changing medicines to patients.

Dr. Fehlner joined Novartis in 2008 from Baker Botts, where he was a partner specializing in IP counselling and strategic planning in the pharmaceutical, biotechnology and medical device industries, as well as litigation. His career includes seven years as an associate and partner at Darby & Darby, with earlier experience as Biotechnology Counsel for Rhône-Poulenc Rorer and as an associate for boutique IP firm Klauber & Jackson. Dr. Fehlner started his career in life sciences law in 1990 as a law clerk in the biotech and pharmaceutical group at Pennie & Edmonds. In addition to life sciences, Dr. Fehlner has worked on chemical and material sciences technologies.

Dr. Fehlner has a JD from Fordham University School of Law, a PhD in immunology and biochemistry from Rockefeller University (Lois P Markey Fellow), and a BS in chemistry from Haverford College (high honors; Phi Beta Kappa).

Paul Fehlner is associated with the following items:
Web Segment  Web Segment Breakout Session No. 2a—Licensing Issues in the Life Sciences Industry - Advanced Licensing Agreements 2018, Thursday, March 08, 2018
MP3 Audio  MP3 Audio Breakout Session No. 2a—Licensing Issues in the Life Sciences Industry - Breakout Session No. 2a—Licensing Issues in the Life Sciences Industry, Thursday, March 08, 2018
MP4 - Mobile Video Seg  MP4 - Mobile Video Seg Breakout Session No. 2a—Licensing Issues in the Life Sciences Industry - Breakout Session No. 2a—Licensing Issues in the Life Sciences Industry, Thursday, March 08, 2018
On-Demand Web Programs  On-Demand Web Programs Advanced Licensing Agreements 2018, Tuesday, March 13, 2018, New York, NY
Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • YouTube
  • RSS

All Contents Copyright © 1996-2018 Practising Law Institute. Continuing Legal Education since 1933.

© 2018 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.